ATE1019T1 - Hyaluronidase und seine herstellung. - Google Patents

Hyaluronidase und seine herstellung.

Info

Publication number
ATE1019T1
ATE1019T1 AT79101420T AT79101420T ATE1019T1 AT E1019 T1 ATE1019 T1 AT E1019T1 AT 79101420 T AT79101420 T AT 79101420T AT 79101420 T AT79101420 T AT 79101420T AT E1019 T1 ATE1019 T1 AT E1019T1
Authority
AT
Austria
Prior art keywords
hyaluronidase
manufacture
chondroitin
hexosaminidase
endo
Prior art date
Application number
AT79101420T
Other languages
English (en)
Inventor
Keizo Yoshida
Takashi Musashiseki Mansion 604 Fujii
Hiroyuki Kikuchi
Original Assignee
Fujisawa Pharmaceutical Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co. Ltd. filed Critical Fujisawa Pharmaceutical Co. Ltd.
Application granted granted Critical
Publication of ATE1019T1 publication Critical patent/ATE1019T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT79101420T 1978-05-11 1979-05-10 Hyaluronidase und seine herstellung. ATE1019T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53056313A JPS6033474B2 (ja) 1978-05-11 1978-05-11 新規なヒアルロニダ−ゼbmp−8231およびその製造法
EP79101420A EP0005751B1 (de) 1978-05-11 1979-05-10 Hyaluronidase und seine Herstellung

Publications (1)

Publication Number Publication Date
ATE1019T1 true ATE1019T1 (de) 1982-05-15

Family

ID=13023655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79101420T ATE1019T1 (de) 1978-05-11 1979-05-10 Hyaluronidase und seine herstellung.

Country Status (5)

Country Link
US (1) US4258134A (de)
EP (1) EP0005751B1 (de)
JP (1) JPS6033474B2 (de)
AT (1) ATE1019T1 (de)
DE (1) DE2962780D1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801475A (en) * 1984-08-23 1989-01-31 Gregory Halpern Method of hydrophilic coating of plastics
GB8504025D0 (en) * 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
SE456245B (sv) * 1986-07-09 1988-09-19 Pharmacia Ab Enzympreparation innehallande krillhyaluronidas
JP2699078B2 (ja) * 1987-12-23 1998-01-19 北里研究所(社団法人) ムシン分解酵素及びその製造法
US6610292B2 (en) 1995-11-22 2003-08-26 Ista Pharmaceuticals, Inc. Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
US5866120A (en) 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
EP1061873B1 (de) * 1998-03-09 2005-11-02 Ista Pharmaceuticals, Inc Verwendung von glyceraldehyde als hornhaut härtungsmitteln
ATE302785T1 (de) 1998-04-30 2005-09-15 Maruha Corp Verbindungen, deren struktur derivate von glukuronsäure und glukosamin enthält, verfahren zu deren herstellung und deren verwendung
RU2174557C1 (ru) * 2000-11-22 2001-10-10 Предприятие по производству бакпрепаратов научно-исследовательского института эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН Способ получения гиалуронидазы стрептококковой
EP2163643B1 (de) 2003-03-05 2015-01-21 Halozyme, Inc. Lösliches Hyaluronidaseglykoprotein (sHASEGP), Verfahren zu dessen Herstellung, Verwendungen und pharmazeutische Zusammensetzungen, die dieses umfassen
MXPA03011987A (es) 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
BRPI0907371A2 (pt) 2008-01-09 2015-11-24 Sanofi Aventis Deutschland derivados de insulina com um perfil de tempo-ação muito retardado
RS59913B1 (sr) 2008-10-17 2020-03-31 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
US20120219554A2 (en) * 2009-05-14 2012-08-30 Fidia Farmaceutici S.P.A. Extracellular yaluronidase from streptomyces koganeiensis
BR112012000177B1 (pt) * 2009-07-06 2021-06-01 Sanofi-Aventis Deutschland Gmbh Formulação farmacêutica aquosa contendo metionina, processo para sua preparação, uso da mesma e medicamento para tratar diabetes mellitus
ES2534191T3 (es) 2009-11-13 2015-04-20 Sanofi-Aventis Deutschland Gmbh Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
CA2780043C (en) 2009-11-13 2019-01-29 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a glp-1 agonist and methionine
CZ302504B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
SG187904A1 (en) 2010-08-30 2013-04-30 Sanofi Aventis Deutschland Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
CZ303879B6 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
JP2015524580A (ja) 2012-08-10 2015-08-24 オシオ コーポレイション ディー/ビー/エー ヨリア ヘルス 眼科的状態の治療におけるコンタクトレンズ使用
CZ2012664A3 (cs) 2012-09-27 2013-11-13 Contipro Biotech S.R.O. Enzym hyaluronan-lyáza, zpusob jeho výroby, pouzití a zpusob prípravy nízkomolekulárního hyaluronanu
CZ2012842A3 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
TWI780236B (zh) 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
WO2014186310A1 (en) 2013-05-13 2014-11-20 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
ITMI20130992A1 (it) 2013-06-17 2014-12-18 Fidia Farmaceutici Ialuronidasi batterica e metodo per la sua produzione
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
KR20160104724A (ko) 2014-01-09 2016-09-05 사노피 인슐린 유사체 및/또는 인슐린 유도체의 안정화된 약제학적 제형
CN105899190B (zh) 2014-01-09 2022-06-14 赛诺菲 门冬胰岛素的稳定化药物制剂
CN105899191B (zh) 2014-01-09 2020-06-16 赛诺菲 胰岛素类似物和/或胰岛素衍生物的稳定化不含甘油的药物制剂
CZ305153B6 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CZ306479B6 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1946682A1 (de) 1968-09-21 1971-01-28 Amano Pharma Co Ltd Verfahren zur Herstellung von Hyaluronidase
US3728223A (en) * 1971-10-08 1973-04-17 Amano Pharma Co Ltd Production of hyaluronidase from a strain of streptomyces
JPS5413510B2 (de) * 1973-08-28 1979-05-31
SU513075A1 (ru) * 1974-09-09 1976-05-05 Московский технологический институт пищевой промышленности Способ получени гиалуронидазы

Also Published As

Publication number Publication date
JPS54147997A (en) 1979-11-19
EP0005751A1 (de) 1979-12-12
JPS6033474B2 (ja) 1985-08-02
EP0005751B1 (de) 1982-05-12
US4258134A (en) 1981-03-24
DE2962780D1 (en) 1982-07-01

Similar Documents

Publication Publication Date Title
ATE1019T1 (de) Hyaluronidase und seine herstellung.
ATE22104T1 (de) Herstellung von pyrrolo-(3,4-c)-pyrrolen.
DE3872495D1 (de) Herstellung von 3,3,3-trifluoropropen.
FI73995B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6,11-dihydro-dibenso-/b,e/-tiepin-11-n-alkyl- norskopinetrar.
FI851637A0 (fi) 1,4-dihydro-4-oxonaftyridinderivat och deras salter, foerfarande foer framstaellning av dessa och dessa omfattande antibakteriella aemnen.
FI822990A7 (fi) Rasian suljin.
BG30314A3 (bg) Фунгицидно средство
ES262762Y (es) "estructura de casquillo".
GB2083459B (en) New substituted heterocyclic benzamides and their production
ATE1500T1 (de) 6-chlor-2,3-dihydroxy-1,4-naphthochinon und seine 2,3-diester, und ihre herstellung.
DK240979A (da) 3-azabicyclo (3,1,0) hexanderivater
ATE97554T1 (de) Herstellung von flocken.
NL7903010A (nl) Plantenkweeklichaam.
AR241108A2 (es) Insecticidas piretroides, acidos ciclopropancarboxilicos y esteres intermediarios y sus precedimientos de preparacion
FI790831A7 (fi) Foerfarande foer framstaellning av 1-oxo-1h-pyrimido(6,1-b)bentstiazolderivat
NO885465L (no) Absorpsjon av hydrogensulfid.
ATE132500T1 (de) 24r-scymnol, herstellung und verwendung
NL7903973A (nl) 1,2,4-triazolidinonen-3 en thionen-3.
DK266679A (da) 3-azabicyclo (3.1.0) hexanderivater
BG28978A3 (en) Fungicide means and method for fighting the fungus
DE69105966D1 (de) Herstellung von sphärischen faseraggregat.
DK241079A (da) 3-azabicyclo (3,1,0) hexanderivater
DE3782698D1 (de) 5-fluoruridin-derivat und dessen herstellung.
BE875273A (fr) 0-carbamoyloximes de 2,3-dihydro-4h-1-benzo-pyranne-4-ones
SU673818A1 (ru) Вентил ционное устройство

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee